Jiangsu Province Centers for Disease Control and Prevention
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Employees
- -
- Market Cap
- -
- Website
- http://www.jstd.gov.cn/
Clinical Trials
71
Active:1
Completed:61
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:18
Phase 2:13
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (68 trials with phase data)• Click on a phase to view related trials
Phase 1
18 (26.5%)Phase 3
17 (25.0%)Phase 4
16 (23.5%)Phase 2
13 (19.1%)Early Phase 1
2 (2.9%)Not Applicable
2 (2.9%)Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
Phase 2
Completed
- Conditions
- Streptococcus Pneumoniae Pneumonia
- Interventions
- Biological: low dose-1Biological: low dose-2Biological: high doseBiological: positive control
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Target Recruit Count
- 992
- Registration Number
- NCT07035054
- Locations
- 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
Early Phase 1
Completed
- Conditions
- Streptococcus Pneumoniae Pneumonia
- Interventions
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-18
- Target Recruit Count
- 240
- Registration Number
- NCT07025876
- Locations
- 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine
Phase 4
Completed
- Conditions
- Influenza
- Interventions
- Biological: Intranasal Influenza Live Attenuated Vaccine
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 200
- Registration Number
- NCT06609811
- Locations
- 🇨🇳
Haizhou District Center for Disease Control and Prevention, Lianyungang, Jiangsu, China
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
Not Applicable
Recruiting
- Conditions
- PertussisDiphtheriaTetanusHaemophilus Influenzae Type B InfectionPolio
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-09-20
- Target Recruit Count
- 785
- Registration Number
- NCT06605755
- Locations
- 🇨🇳
Jingsu Provincial Centre of Disease Control and Prevention, Nanjing, Jiangsu, China
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
Phase 4
Active, not recruiting
- Conditions
- Hand, Foot and Mouth Disease
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Target Recruit Count
- 510
- Registration Number
- NCT06209398
- Locations
- 🇨🇳
Jiangsu Province Centers for Disease Control and Prevention, Nanjing, Jiangsu, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
No news found